PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | C2711227|hepatic steatosis |
| Sentences | 15 |
| PubMedID- 24349054 | In the near future, transient elastography will be useful for the evaluation of hepatic fibrosis in chronic hepatitis c patients with hepatic steatosis. |
| PubMedID- 24050726 | Lipid profile and hepatic steatosis in hepatitis c infected egyptian survivors of childhood cancer. |
| PubMedID- 20847561 | Background: the pathogenic mechanisms of hepatic steatosis in hepatitis c (hcv) remain unclear. |
| PubMedID- 25869759 | Then, we divided the study group into two groups-group 1: ibd + dyspepsia + hepatitis c without hepatic steatosis, and group 2: hepatitis c with hepatic steatosis + nafld-and performed the same analysis. |
| PubMedID- 20178560 | hepatic steatosis in hepatitis c is a storage disease due to hcv interaction with microsomal triglyceride transfer protein (mtp). |
| PubMedID- 21703198 | Beneficial il28b genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis c. |
| PubMedID- 21199519 | The clinical relevance of hepatic steatosis in patients with chronic hepatitis c includes a close correlation with hepatic fibrosis, and a poor response to combination peginterferon and ribavirin treatment. |
| PubMedID- 26214341 | Pioglitazone for hepatic steatosis in hiv/hepatitis c virus coinfection. |
| PubMedID- 20714438 | Increasing studies on chronic hepatitis c with hepatic steatosis have been conducted, but little is known about chb with steatosis. |
| PubMedID- 20495737 | Background: recent findings suggest a higher prevalence of hepatic steatosis in patients with chronic hepatitis c, estimated at 50%. |
| PubMedID- 21054524 | Conclusions: amino acid substitutions in the hcv genotype 1b core region are associated with hepatic steatosis in patients with chronic hepatitis c, independent of glucose intolerance. |
| PubMedID- 20672387 | hepatic steatosis with hepatitis b virus/hepatitis c virus dual infection. |
| PubMedID- 20931285 | Background: hepatic steatosis in hepatitis c virus (hcv)-infected patients has been shown to enhance the progression of liver fibrosis and decrease the response to antiviral therapy. |
| PubMedID- 22701799 | Insulin resistance or impaired glucose metabolism, is linked to hepatic steatosis in patients with chronic hepatitis c (ch-c). |
| PubMedID- 24810965 | Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis c virus infection. |
Page: 1